{{Rsnum
|rsid=7139958
|Gene=DAOA
|Chromosome=13
|position=105484383
|Orientation=plus
|GMAF=0.3976
|Gene_s=DAOA
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 10.8 | 49.2 | 40.0
| HCB | 31.1 | 46.7 | 22.2
| JPT | 43.2 | 38.6 | 18.2
| YRI | 0.0 | 11.1 | 88.9
| ASW | 0.0 | 0.0 | 0.0
| CHB | 31.1 | 46.7 | 22.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22122005
|Title=DAOA variants and schizophrenia: influence on diagnosis and treatment outcomes
}}{{PMID Auto
|PMID=23495896
|Title=Investigation of epistasis between DAOA and 5HTR1A variants on clinical outcomes in patients with schizophrenia.
}}